Accession Number:

AD1040551

Title:

Annual Surveillance Summary: Klebsiella Species Infections in the Military Health System (MHS), 2016

Descriptive Note:

Technical Report,01 Jan 2016,31 Dec 2016

Corporate Author:

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER PORTSMOUTH VA PORTSMOUTH United States

Personal Author(s):

Report Date:

2017-06-01

Pagination or Media Count:

23.0

Abstract:

The EpiData Center Department EDC conducts routine surveillance of Klebsiella species incidence and prevalence among all beneficiaries seeking care within the Military Health System MHS. This report describes demographics, clinical characteristics, prescription practices, and antibiotic resistance patterns observed for Klebsiella species infections in calendar year CY 2016. Multiple data sources were linked to assess descriptive and clinical factors related to Klebsiella. Health Level 7 HL7-formatted Composite Health Care System CHCS microbiology data identified Klebsiella species infections. These infections were matched to HL7-formatted CHCS pharmacy data to assess prescription practices, the Standard Inpatient Data Record SIDR to determine healthcare-associated exposures, Defense Manpower Data Center DMDC rosters to determine burden among Department of Defense DOD active duty AD service members, and the DMDC Contingency Tracking System CTS to determine Department of the Navy DON deployment-related infections. Overall, incidence rates IRs of Klebsiella species infections in the MHS beneficiary and DOD AD populations are increasing. In 2016, the annual Klebsiella species IR increased by 10.8 percent compared to the weighted historic IR this increase was within expected variation of Klebsiella species infections in the MHS populations. For severe nosocomial infections, viable treatment options are still present for Klebsiella species. However, for mild to moderate community-acquired infections uncomplicated urinary tract infection, fluoroquinolones present better treatment options compared to nitrofurans based on susceptibility. Nitrofurantoin as a viable treatment option for Klebsiella species infections within the MHS population warrants further investigation.

Subject Categories:

  • Microbiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE